Inogen Inc INGN
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
4/9
Piotroski F — financial health
2.26
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $348.7M | -$22.7M | $154.3M | -$13.7M | $192.2M |
| 2024 | $335.7M | -$35.9M | $154.7M | $2.6M | $173.9M |
| 2023 | $315.7M | -$102.4M | $126.7M | -$8.5M | $204.8M |
| 2022 | $320.5M | -$83.8M | $153.5M | -$40.9M | $297.4M |
| 2021 | $311.7M | -$6.3M | $176.5M | $18.2M | $370.2M |
| 2020 | $280.2M | -$5.8M | $138.2M | $32.6M | $349.6M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Sahney Mira Kirti | director | 2026-06-05 | Grant | 28,081 | — |
| Boehnlein Glenn S | director | 2026-06-05 | Grant | 28,081 | — |
| Jamali Vafa | director | 2026-06-05 | Grant | 28,081 | — |
| Mora Elizabeth | director | 2026-06-05 | Grant | 28,081 | — |
| Ladone Mary Kay | director | 2026-06-05 | Grant | 28,081 | — |
| King Kevin M | director | 2026-06-05 | Grant | 28,081 | — |
| Rider Heather D. | director | 2026-06-05 | Grant | 28,081 | — |
| Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off | 2026-05-29 | Sell | 10,770 | $6.53 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.26 (grey)
- Working capital / assets 0.451
- Retained earnings / assets -0.588
- EBIT / assets -0.101
- Equity / liabilities 1.807
Source: SEC EDGAR filings · CIK 0001294133 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.